Chatting with Heather M. Fernandez is both fun and informative, always! Lucky to have her working to improve healthcare delivery at Solv. venrock.com/running-throug…

Healthcare landscape predictions...Bob Kocher and I pull out the murky crystal ball - Let us know your favorite...or least. Happy holidays. fortune.com/2022/12/14/fro…

Super fun, (beware - stream of consciousness) conversation about learnings over 3 boom-bust cycles with @jason on @TWiStartups youtube.com/watch?v=Y7cYkt…

Nice survey results for Element Biosciences from the Sequencing Buyers Guide...Even though the Guide is sponsored by the big dog in DNA sequencing...Element Biosciences's Aviti come out on top!

Fun conversation. Thanks for having me. #cheapdate

.Bob Kocher and I are BACK with another year of slightly less than super accurate prognostications about healthcare. All comments and criticism welcome!!! fortune.com/2023/11/14/ai-…

Awesome approach &discoveries by Kole Roybal and Jaehyuk Choi that dramatically changes our understanding of what is possible for solid tumor cell therapy. Formed the basis for Moonlight Bio. nature.com/articles/s4158…

'24-'25 is when VC's will understand how well they did their jobs in '20-'21...

That would be the discounts when they are not going head to head v Element in an account...

Terrific step forward for independent workers by Stride and DoorDash. bloomberg.com/news/articles/…

Great company in a hot market. Suki partnering with Rush University System for Health to make physicians more productive and happier. suki.ai/news/rush-deep…

Will save some 80% of costs…lots of time…get great drugs out there…etc

We have the IT/data capabilities to do it and make it not a hard lift. For sure, one can not count on people doing the right thing all the time (like Amylyx - kudos to Josh & Justin) - but the benefit to all would make it worth the effort

Gazing into our healthcare crystal ball with my excellent colleague Bob Kocher: Medicare Advantage waves; Apple does glucose monitoring; Cell therapy bounces back! fortune.com/2024/12/06/dr-…

Our 9th annual #HealthcarePrognosis results are in, and the findings this year are…interesting. We polled ~300 of our smartest #healthcare friends about founder mode vs. manager mode, exit expectations and AI, obviously. Check out the findings here: bit.ly/4jbjptq

Matt Holt and I go back over 20 years - bonded over Ikaria - before he crushed HCIT from a PE platform. Matt was kind enough to join us for a podcast so we could reminisce about past deals, the evolution of the healthcare sector and project *Sparkle* [spoiler - now Datavant].